Protagonist Therapeutics (PTGX) Return on Capital Employed Growth (3y) (2019 - 2026)
Protagonist Therapeutics (PTGX) Return on Capital Employed Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -3,782.00 |
| 10 | Protagonist Therapeutics | 8.86 Bn | 8.86 Bn | - | 4,432.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,432.00 |
| Dec 31, 2025 | 3,145.00 |
| Sep 30, 2025 | 5,366.00 |
| Jun 30, 2025 | 4,959.00 |
| Mar 31, 2025 | 4,421.00 |
| Dec 31, 2024 | 8,010.00 |
| Sep 30, 2024 | 5,721.00 |
| Jun 30, 2024 | 5,268.00 |
| Mar 31, 2024 | 5,764.00 |
| Dec 31, 2023 | -105.00 |
| Sep 30, 2023 | -1,703.00 |
| Jun 30, 2023 | -794.00 |
| Mar 31, 2023 | 1,255.00 |
| Dec 31, 2022 | 1,128.00 |
| Sep 30, 2022 | 1,441.00 |
| Jun 30, 2022 | 2,017.00 |
| Mar 31, 2022 | 335.00 |
| Dec 31, 2021 | -395.00 |
| Sep 30, 2021 | -529.00 |
| Jun 30, 2021 | -374.00 |